Cargando…

Acute protein kinase C beta inhibition preserves coronary endothelial function after cardioplegic hypoxia/reoxygenation

OBJECTIVE: Protein kinase C (PKC) influences myocardial contractility and susceptibility to long-term cardiac dysfunction after ischemia–reperfusion injury. In diabetes, PKC inhibition has a protective effect in terms of microvascular dysfunction. SK-channel dysfunction also influences endothelial d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kant, Shawn, Xing, Hang, Liu, Yuhong, Harrington, Elizabeth O., Sellke, Frank W., Feng, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556935/
https://www.ncbi.nlm.nih.gov/pubmed/37808045
http://dx.doi.org/10.1016/j.xjon.2023.06.014
_version_ 1785116977577066496
author Kant, Shawn
Xing, Hang
Liu, Yuhong
Harrington, Elizabeth O.
Sellke, Frank W.
Feng, Jun
author_facet Kant, Shawn
Xing, Hang
Liu, Yuhong
Harrington, Elizabeth O.
Sellke, Frank W.
Feng, Jun
author_sort Kant, Shawn
collection PubMed
description OBJECTIVE: Protein kinase C (PKC) influences myocardial contractility and susceptibility to long-term cardiac dysfunction after ischemia–reperfusion injury. In diabetes, PKC inhibition has a protective effect in terms of microvascular dysfunction. SK-channel dysfunction also influences endothelial dysfunction in cardioplegic hypoxia–reoxygenation (CP-H/R). Here, we examine whether acute inhibition of PKC beta protects against CP-H/R–induced coronary endothelial and SK channel dysfunction. METHODS: Isolated mouse coronary arterioles, half pretreated with selective PKC inhibitor ruboxistaurin (RBX), were subjected to hyperkalemic, cardioplegic hypoxia (1 hour), and reoxygenation (1 hour) with Krebs buffer. Sham control vessels were continuously perfused with oxygenated Krebs buffer without CP-H/R. After 1 hour of reoxygenation, responses to the endothelium-dependent vasodilator adenosine-diphosphate (ADP) and the SK-channel activator NS309 were examined. Endothelial SK-specific potassium currents from mouse heart endothelial cells were examined using whole-cell path clamp configurations in response to NS309 and SK channel blockers apamin and TRAM34. RESULTS: CP-H/R significantly decreased coronary relaxation responses to ADP (P = .006) and NS309 (P = .0001) compared with the sham control group. Treatment with selective PKC beta inhibitor RBX significantly increased recovery of coronary relaxation responses to ADP (P = .031) and NS309 (P = .004) after CP-H/R. Treatment with RBX significantly increased NS309-mediated potassium currents following CP-H/R (P = .0415). Apamin and TRAM34 sensitive currents were significantly greater in CP-H/R + RBX versus CP-H/R mouse heart endothelial cells (P = .0027). CONCLUSIONS: Acute inhibition of PKC beta significantly protected mouse coronary endothelial function after CP-H/R injury. This suggests that acute PKC beta inhibition may be a novel approach for preventing microvascular dysfunction during CP-H/R.
format Online
Article
Text
id pubmed-10556935
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105569352023-10-07 Acute protein kinase C beta inhibition preserves coronary endothelial function after cardioplegic hypoxia/reoxygenation Kant, Shawn Xing, Hang Liu, Yuhong Harrington, Elizabeth O. Sellke, Frank W. Feng, Jun JTCVS Open Adult: Coronary: Basic Science OBJECTIVE: Protein kinase C (PKC) influences myocardial contractility and susceptibility to long-term cardiac dysfunction after ischemia–reperfusion injury. In diabetes, PKC inhibition has a protective effect in terms of microvascular dysfunction. SK-channel dysfunction also influences endothelial dysfunction in cardioplegic hypoxia–reoxygenation (CP-H/R). Here, we examine whether acute inhibition of PKC beta protects against CP-H/R–induced coronary endothelial and SK channel dysfunction. METHODS: Isolated mouse coronary arterioles, half pretreated with selective PKC inhibitor ruboxistaurin (RBX), were subjected to hyperkalemic, cardioplegic hypoxia (1 hour), and reoxygenation (1 hour) with Krebs buffer. Sham control vessels were continuously perfused with oxygenated Krebs buffer without CP-H/R. After 1 hour of reoxygenation, responses to the endothelium-dependent vasodilator adenosine-diphosphate (ADP) and the SK-channel activator NS309 were examined. Endothelial SK-specific potassium currents from mouse heart endothelial cells were examined using whole-cell path clamp configurations in response to NS309 and SK channel blockers apamin and TRAM34. RESULTS: CP-H/R significantly decreased coronary relaxation responses to ADP (P = .006) and NS309 (P = .0001) compared with the sham control group. Treatment with selective PKC beta inhibitor RBX significantly increased recovery of coronary relaxation responses to ADP (P = .031) and NS309 (P = .004) after CP-H/R. Treatment with RBX significantly increased NS309-mediated potassium currents following CP-H/R (P = .0415). Apamin and TRAM34 sensitive currents were significantly greater in CP-H/R + RBX versus CP-H/R mouse heart endothelial cells (P = .0027). CONCLUSIONS: Acute inhibition of PKC beta significantly protected mouse coronary endothelial function after CP-H/R injury. This suggests that acute PKC beta inhibition may be a novel approach for preventing microvascular dysfunction during CP-H/R. Elsevier 2023-07-06 /pmc/articles/PMC10556935/ /pubmed/37808045 http://dx.doi.org/10.1016/j.xjon.2023.06.014 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Adult: Coronary: Basic Science
Kant, Shawn
Xing, Hang
Liu, Yuhong
Harrington, Elizabeth O.
Sellke, Frank W.
Feng, Jun
Acute protein kinase C beta inhibition preserves coronary endothelial function after cardioplegic hypoxia/reoxygenation
title Acute protein kinase C beta inhibition preserves coronary endothelial function after cardioplegic hypoxia/reoxygenation
title_full Acute protein kinase C beta inhibition preserves coronary endothelial function after cardioplegic hypoxia/reoxygenation
title_fullStr Acute protein kinase C beta inhibition preserves coronary endothelial function after cardioplegic hypoxia/reoxygenation
title_full_unstemmed Acute protein kinase C beta inhibition preserves coronary endothelial function after cardioplegic hypoxia/reoxygenation
title_short Acute protein kinase C beta inhibition preserves coronary endothelial function after cardioplegic hypoxia/reoxygenation
title_sort acute protein kinase c beta inhibition preserves coronary endothelial function after cardioplegic hypoxia/reoxygenation
topic Adult: Coronary: Basic Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556935/
https://www.ncbi.nlm.nih.gov/pubmed/37808045
http://dx.doi.org/10.1016/j.xjon.2023.06.014
work_keys_str_mv AT kantshawn acuteproteinkinasecbetainhibitionpreservescoronaryendothelialfunctionaftercardioplegichypoxiareoxygenation
AT xinghang acuteproteinkinasecbetainhibitionpreservescoronaryendothelialfunctionaftercardioplegichypoxiareoxygenation
AT liuyuhong acuteproteinkinasecbetainhibitionpreservescoronaryendothelialfunctionaftercardioplegichypoxiareoxygenation
AT harringtonelizabetho acuteproteinkinasecbetainhibitionpreservescoronaryendothelialfunctionaftercardioplegichypoxiareoxygenation
AT sellkefrankw acuteproteinkinasecbetainhibitionpreservescoronaryendothelialfunctionaftercardioplegichypoxiareoxygenation
AT fengjun acuteproteinkinasecbetainhibitionpreservescoronaryendothelialfunctionaftercardioplegichypoxiareoxygenation